High-dose therapy/autologous hematopoietic stem cell transplantation in relapsed or refractory marginal zone non-hodgkin lymphoma

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue 3, 2011, Pages 253-256

  Li, Lanfang ^a   Bierman, Philip ^b   Vose, Julie ^b   Loberiza, Fausto ^b   Armitage, James O ^b   Bociek, R Gregory ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Autologous HSCT; Marginal zone; Non hodgkin lymphoma

Indexed keywords

BLEOMYCIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; MELPHALAN; MESNA; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RESISTANCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; MALE; MARGINAL ZONE LYMPHOMA; MORTALITY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIMODALITY CANCER THERAPY; MYELODYSPLASTIC SYNDROME; NODAL MARGINAL ZONE LYMPHOMA; OVERALL SURVIVAL; PATIENT SAFETY; RADIATION DOSE; RETROSPECTIVE STUDY; SPLENIC MARGINAL ZONE LYMPHOMA; STOMACH CARCINOMA; SURVIVAL TIME; TREATMENT FAILURE; WHOLE BODY RADIATION; AUTOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; RECURRENT DISEASE; SURVIVAL; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 80053363011     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2011.03.011     Document Type: Article

References (15)

1. S.H. Swerdlow WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. 2008 International Agency for Rsearch on Cancer Lyon, France
2. P.G. Isaacson Mucosa-associated lymphoid tissue lymphoma Semin Hematol 36 1999 139 147 (Pubitemid 29214067)
3. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma The Non-Hodgkin's Lymphoma Classification Project Blood 89 1997 3909 3918
4. C. Doglioni, A.C. Wotherspoon, and A. Moschini High incidence of primary gastric lymphoma in northeastern Italy Lancet 339 1992 834 835 [see comments]
5. R.W. Tsang, M.K. Gospodarowicz, and M. Pintilie Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome J Clin Oncol 21 2003 4157 4164 (Pubitemid 46606184)
6. F. Berger, P. Felman, and C. Thieblemont Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients Blood 95 2000 1950 1956 (Pubitemid 30151631)
7. D. Catovsky, and E. Matutes Splenic lymphoma with circulating villous lymphocytes/splenic marginal- zone lymphoma Semin Hematol 36 1999 148 154 (Pubitemid 29214068)
8. T.E. Witzig, S.M. Geyer, and P.J. Kurtin Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group Leuk Lymphoma 49 2008 1074 1080 (Pubitemid 351943252)
9. M.F. Leahy, J.F. Seymour, and R.J. Hicks Multicenter phase II clinical study of iodine-131-rituximab radioimmunotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma J Clin Oncol 24 2006 4418 4425 (Pubitemid 46646247)
10. A. Conconi, G. Martinelli, and C. Thieblemont Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type Blood 102 2003 2741 2745 (Pubitemid 37248842)
11. G. Jager, P. Neumeister, and R. Brezinschek Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study J Clin Oncol 20 2002 3872 3877
12. C. Kalpadakis, G.A. Pangalis, and M.N. Dimopoulou Rituximab monotherapy is highly effective in splenic marginal zone lymphoma Hematol Oncol 25 2007 127 131 (Pubitemid 47507880)
13. M. Raderer, B. Streubel, and S. Woehrer High relapse rate in patients with MALT lymphoma warrants lifelong follow-up Clin Cancer Res 11 2005 3349 3352 (Pubitemid 40627886)
14. J.R. Brown, G. Gaudet, and J.W. Friedberg Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma Leuk Lymphoma 45 2004 315 320 (Pubitemid 38181434)
15. H.C. Schouten, W. Qian, and S. Kvaloy High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial J Clin Oncol 21 2003 3918 3927 (Pubitemid 46606204)